0GZX Stock Overview
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
DiaSorin S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €95.66 |
| 52 Week High | €106.81 |
| 52 Week Low | €81.30 |
| Beta | 0.15 |
| 1 Month Change | 8.36% |
| 3 Month Change | 13.15% |
| 1 Year Change | -1.73% |
| 3 Year Change | -33.62% |
| 5 Year Change | 9.39% |
| Change since IPO | 708.62% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0GZX | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 9.6% | 2.0% | 2.7% |
| 1Y | -1.7% | -8.5% | 0.3% |
Return vs Industry: 0GZX exceeded the UK Medical Equipment industry which returned -10.7% over the past year.
Return vs Market: 0GZX matched the UK Market which returned -1.8% over the past year.
Price Volatility
| 0GZX volatility | |
|---|---|
| 0GZX Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0GZX has not had significant price volatility in the past 3 months.
Volatility Over Time: 0GZX's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 3,209 | Carlo Rosa | diasoringroup.com/en |
DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System.
DiaSorin S.p.A. Fundamentals Summary
| 0GZX fundamental statistics | |
|---|---|
| Market cap | €5.12b |
| Earnings (TTM) | €159.85m |
| Revenue (TTM) | €1.15b |
32.0x
P/E Ratio4.5x
P/S RatioIs 0GZX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0GZX income statement (TTM) | |
|---|---|
| Revenue | €1.15b |
| Cost of Revenue | €407.02m |
| Gross Profit | €741.19m |
| Other Expenses | €581.34m |
| Earnings | €159.85m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 10, 2024
| Earnings per share (EPS) | 3.00 |
| Gross Margin | 64.55% |
| Net Profit Margin | 13.92% |
| Debt/Equity Ratio | 72.9% |
How did 0GZX perform over the long term?
See historical performance and comparisonDividends
1.2%
Current Dividend Yield40%
Payout RatioDoes 0GZX pay a reliable dividends?
See 0GZX dividend history and benchmarks| DiaSorin dividend dates | |
|---|---|
| Ex Dividend Date | May 20 2024 |
| Dividend Pay Date | May 22 2024 |
| Days until Ex dividend | 25 days |
| Days until Dividend pay date | 27 days |
Does 0GZX pay a reliable dividends?
See 0GZX dividend history and benchmarks